Annual Cash & Cash Equivalents:
$890.06M+$372.27M(+71.90%)Summary
- As of today, GMED annual cash & cash equivalents is $890.06 million, with the most recent change of +$372.27 million (+71.90%) on December 31, 2024.
- During the last 3 years, GMED annual cash & cash equivalents has risen by +$446.61 million (+100.71%).
- GMED annual cash & cash equivalents is now at all-time high.
Performance
GMED Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$390.52M+$161.08M(+70.20%)Summary
- As of today, GMED quarterly cash & cash equivalents is $390.52 million, with the most recent change of +$161.08 million (+70.20%) on September 30, 2025.
- Over the past year, GMED quarterly cash & cash equivalents has dropped by -$304.18 million (-43.79%).
- GMED quarterly cash & cash equivalents is now -56.12% below its all-time high of $890.06 million, reached on December 31, 2024.
Performance
GMED Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GMED Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +71.9% | -43.8% |
| 3Y3 Years | +100.7% | -3.6% |
| 5Y5 Years | +185.7% | -4.7% |
GMED Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +100.7% | -56.1% | +70.2% |
| 5Y | 5-Year | at high | +185.7% | -56.1% | +70.2% |
| All-Time | All-Time | at high | +696.8% | -56.1% | +173.7% |
GMED Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $390.52M(+70.2%) |
| Jun 2025 | - | $229.45M(-50.3%) |
| Mar 2025 | - | $461.27M(-48.2%) |
| Dec 2024 | $890.06M(+71.9%) | $890.06M(+28.1%) |
| Sep 2024 | - | $694.71M(+40.9%) |
| Jun 2024 | - | $492.93M(+13.5%) |
| Mar 2024 | - | $434.47M(-16.1%) |
| Dec 2023 | $517.79M(+16.1%) | $517.79M(+10.4%) |
| Sep 2023 | - | $468.93M(-23.5%) |
| Jun 2023 | - | $612.83M(+21.5%) |
| Mar 2023 | - | $504.37M(+13.1%) |
| Dec 2022 | $446.06M(+0.6%) | $446.06M(+10.1%) |
| Sep 2022 | - | $405.29M(-0.7%) |
| Jun 2022 | - | $408.01M(-13.8%) |
| Mar 2022 | - | $473.29M(+6.7%) |
| Dec 2021 | $443.45M(+3.9%) | $443.45M(-19.8%) |
| Sep 2021 | - | $553.20M(+20.1%) |
| Jun 2021 | - | $460.43M(+14.1%) |
| Mar 2021 | - | $403.56M(-5.4%) |
| Dec 2020 | $426.74M(+37.0%) | $426.74M(+4.2%) |
| Sep 2020 | - | $409.64M(+29.3%) |
| Jun 2020 | - | $316.74M(+14.4%) |
| Mar 2020 | - | $276.95M(-11.1%) |
| Dec 2019 | $311.49M(-8.3%) | $311.49M(+12.2%) |
| Sep 2019 | - | $277.59M(+15.5%) |
| Jun 2019 | - | $240.43M(-25.0%) |
| Mar 2019 | - | $320.66M(-5.6%) |
| Dec 2018 | $339.68M | $339.68M(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $372.76M(+3.3%) |
| Jun 2018 | - | $360.92M(-2.2%) |
| Mar 2018 | - | $369.18M(-1.2%) |
| Dec 2017 | $373.71M(+28.5%) | $373.71M(+10.7%) |
| Sep 2017 | - | $337.66M(+8.0%) |
| Jun 2017 | - | $312.67M(-4.3%) |
| Mar 2017 | - | $326.57M(+12.3%) |
| Dec 2016 | $290.79M(-5.3%) | $290.79M(+12.5%) |
| Sep 2016 | - | $258.40M(-23.0%) |
| Jun 2016 | - | $335.75M(+2.2%) |
| Mar 2016 | - | $328.58M(+7.0%) |
| Dec 2015 | $307.15M(+21.8%) | $307.15M(+16.3%) |
| Sep 2015 | - | $263.99M(+17.6%) |
| Jun 2015 | - | $224.49M(-5.1%) |
| Mar 2015 | - | $236.65M(-6.1%) |
| Dec 2014 | $252.07M(+5.5%) | $252.07M(-15.6%) |
| Sep 2014 | - | $298.75M(+8.1%) |
| Jun 2014 | - | $276.26M(-1.6%) |
| Mar 2014 | - | $280.81M(+17.5%) |
| Dec 2013 | $238.92M(+12.5%) | $238.92M(+12.1%) |
| Sep 2013 | - | $213.15M(+32.3%) |
| Jun 2013 | - | $161.16M(-0.7%) |
| Mar 2013 | - | $162.33M(-23.6%) |
| Dec 2012 | $212.40M(+48.9%) | $212.40M(+8.8%) |
| Sep 2012 | - | $195.16M(+17.9%) |
| Jun 2012 | - | $165.58M(+4.1%) |
| Mar 2012 | - | $159.10M(+11.5%) |
| Dec 2011 | $142.67M(+27.7%) | $142.67M |
| Dec 2010 | $111.70M | - |
FAQ
- What is Globus Medical, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Globus Medical, Inc.?
- What is Globus Medical, Inc. annual cash & cash equivalents year-on-year change?
- What is Globus Medical, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Globus Medical, Inc.?
- What is Globus Medical, Inc. quarterly cash & cash equivalents year-on-year change?
What is Globus Medical, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of GMED is $890.06M
What is the all-time high annual cash & cash equivalents for Globus Medical, Inc.?
Globus Medical, Inc. all-time high annual cash & cash equivalents is $890.06M
What is Globus Medical, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, GMED annual cash & cash equivalents has changed by +$372.27M (+71.90%)
What is Globus Medical, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GMED is $390.52M
What is the all-time high quarterly cash & cash equivalents for Globus Medical, Inc.?
Globus Medical, Inc. all-time high quarterly cash & cash equivalents is $890.06M
What is Globus Medical, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, GMED quarterly cash & cash equivalents has changed by -$304.18M (-43.79%)